Global Opioids Drug Market Growth 2023-2029

Publisher Name :
Date: 12-Jan-2023
No. of pages: 104

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

LPI (LP Information)' newest research report, the "Opioids Drug Industry Forecast" looks at past sales and reviews total world Opioids Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioids Drug sales for 2023 through 2029. With Opioids Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioids Drug industry.

This Insight Report provides a comprehensive analysis of the global Opioids Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioids Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Opioids Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioids Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioids Drug.

The global Opioids Drug market size is projected to grow from US$ 9831.4 million in 2022 to US$ 8616.1 million in 2029; it is expected to grow at a CAGR of 8616.1 from 2023 to 2029.

Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Oxycodone

- Hydromorphone

- Codeine

- Fentanyl

Segmentation by application

- Pain Relief

- Anesthesia

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Teva

- Purdue Pharma

- Mallinckrodt

- Amneal Pharma

- Collegium

- J&J

- Endo

- Pfizer

- INSYS

- Mylan

- Hikma

- Egalet

Key Questions Addressed in this Report

What is the 10-year outlook for the global Opioids Drug market?

What factors are driving Opioids Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Opioids Drug market opportunities vary by end market size?

How does Opioids Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Opioids Drug Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioids Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2018, 2022 & 2029
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Opioids Drug Sale Price by Type (2018-2023)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Opioids Drug Sale Price by Application (2018-2023)
3 Global Opioids Drug by Company
3.1 Global Opioids Drug Breakdown Data by Company
3.1.1 Global Opioids Drug Annual Sales by Company (2018-2023)
3.1.2 Global Opioids Drug Sales Market Share by Company (2018-2023)
3.2 Global Opioids Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Opioids Drug Revenue by Company (2018-2023)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2018-2023)
3.3 Global Opioids Drug Sale Price by Company
3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Opioids Drug by Geographic Region
4.1 World Historic Opioids Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Opioids Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Opioids Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Opioids Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Opioids Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Opioids Drug Sales Growth
4.4 APAC Opioids Drug Sales Growth
4.5 Europe Opioids Drug Sales Growth
4.6 Middle East & Africa Opioids Drug Sales Growth
5 Americas
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2018-2023)
5.1.2 Americas Opioids Drug Revenue by Country (2018-2023)
5.2 Americas Opioids Drug Sales by Type
5.3 Americas Opioids Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2018-2023)
6.1.2 APAC Opioids Drug Revenue by Region (2018-2023)
6.2 APAC Opioids Drug Sales by Type
6.3 APAC Opioids Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2018-2023)
7.1.2 Europe Opioids Drug Revenue by Country (2018-2023)
7.2 Europe Opioids Drug Sales by Type
7.3 Europe Opioids Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Opioids Drug Sales by Type
8.3 Middle East & Africa Opioids Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Drug
10.3 Manufacturing Process Analysis of Opioids Drug
10.4 Industry Chain Structure of Opioids Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Drug Distributors
11.3 Opioids Drug Customer
12 World Forecast Review for Opioids Drug by Geographic Region
12.1 Global Opioids Drug Market Size Forecast by Region
12.1.1 Global Opioids Drug Forecast by Region (2024-2029)
12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Drug Forecast by Type
12.7 Global Opioids Drug Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Drug Product Portfolios and Specifications
13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Drug Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Drug Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Drug Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Drug Product Portfolios and Specifications
13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Drug Product Portfolios and Specifications
13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Drug Product Portfolios and Specifications
13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Drug Product Portfolios and Specifications
13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Drug Product Portfolios and Specifications
13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Drug Product Portfolios and Specifications
13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Drug Product Portfolios and Specifications
13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Drug Product Portfolios and Specifications
13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Global Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 8. Global Opioids Drug Sales Market Share by Type (2018-2023)
Table 9. Global Opioids Drug Revenue by Type (2018-2023) & ($ million)
Table 10. Global Opioids Drug Revenue Market Share by Type (2018-2023)
Table 11. Global Opioids Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 13. Global Opioids Drug Sales Market Share by Application (2018-2023)
Table 14. Global Opioids Drug Revenue by Application (2018-2023)
Table 15. Global Opioids Drug Revenue Market Share by Application (2018-2023)
Table 16. Global Opioids Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 18. Global Opioids Drug Sales Market Share by Company (2018-2023)
Table 19. Global Opioids Drug Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Opioids Drug Revenue Market Share by Company (2018-2023)
Table 21. Global Opioids Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 23. Players Opioids Drug Products Offered
Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioids Drug Sales by Geographic Region (2018-2023) & (M Units)
Table 28. Global Opioids Drug Sales Market Share Geographic Region (2018-2023)
Table 29. Global Opioids Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Opioids Drug Sales by Country/Region (2018-2023) & (M Units)
Table 32. Global Opioids Drug Sales Market Share by Country/Region (2018-2023)
Table 33. Global Opioids Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 36. Americas Opioids Drug Sales Market Share by Country (2018-2023)
Table 37. Americas Opioids Drug Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Opioids Drug Revenue Market Share by Country (2018-2023)
Table 39. Americas Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 40. Americas Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 41. APAC Opioids Drug Sales by Region (2018-2023) & (M Units)
Table 42. APAC Opioids Drug Sales Market Share by Region (2018-2023)
Table 43. APAC Opioids Drug Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Opioids Drug Revenue Market Share by Region (2018-2023)
Table 45. APAC Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 46. APAC Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 47. Europe Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 48. Europe Opioids Drug Sales Market Share by Country (2018-2023)
Table 49. Europe Opioids Drug Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Opioids Drug Revenue Market Share by Country (2018-2023)
Table 51. Europe Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 52. Europe Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 53. Middle East & Africa Opioids Drug Sales by Country (2018-2023) & (M Units)
Table 54. Middle East & Africa Opioids Drug Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Opioids Drug Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Opioids Drug Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 58. Middle East & Africa Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 59. Key Market Drivers & Growth Opportunities of Opioids Drug
Table 60. Key Market Challenges & Risks of Opioids Drug
Table 61. Key Industry Trends of Opioids Drug
Table 62. Opioids Drug Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Opioids Drug Distributors List
Table 65. Opioids Drug Customer List
Table 66. Global Opioids Drug Sales Forecast by Region (2024-2029) & (M Units)
Table 67. Global Opioids Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Opioids Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 69. Americas Opioids Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Opioids Drug Sales Forecast by Region (2024-2029) & (M Units)
Table 71. APAC Opioids Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Opioids Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 73. Europe Opioids Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Opioids Drug Sales Forecast by Country (2024-2029) & (M Units)
Table 75. Middle East & Africa Opioids Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Opioids Drug Sales Forecast by Type (2024-2029) & (M Units)
Table 77. Global Opioids Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Opioids Drug Sales Forecast by Application (2024-2029) & (M Units)
Table 79. Global Opioids Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Opioids Drug Product Portfolios and Specifications
Table 82. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Teva Main Business
Table 84. Teva Latest Developments
Table 85. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Purdue Pharma Opioids Drug Product Portfolios and Specifications
Table 87. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Purdue Pharma Main Business
Table 89. Purdue Pharma Latest Developments
Table 90. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Mallinckrodt Opioids Drug Product Portfolios and Specifications
Table 92. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Mallinckrodt Main Business
Table 94. Mallinckrodt Latest Developments
Table 95. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Amneal Pharma Opioids Drug Product Portfolios and Specifications
Table 97. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Amneal Pharma Main Business
Table 99. Amneal Pharma Latest Developments
Table 100. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Collegium Opioids Drug Product Portfolios and Specifications
Table 102. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Collegium Main Business
Table 104. Collegium Latest Developments
Table 105. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. J&J Opioids Drug Product Portfolios and Specifications
Table 107. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. J&J Main Business
Table 109. J&J Latest Developments
Table 110. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Endo Opioids Drug Product Portfolios and Specifications
Table 112. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Endo Main Business
Table 114. Endo Latest Developments
Table 115. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Opioids Drug Product Portfolios and Specifications
Table 117. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. INSYS Opioids Drug Product Portfolios and Specifications
Table 122. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. INSYS Main Business
Table 124. INSYS Latest Developments
Table 125. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan Opioids Drug Product Portfolios and Specifications
Table 127. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Mylan Main Business
Table 129. Mylan Latest Developments
Table 130. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Opioids Drug Product Portfolios and Specifications
Table 132. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Hikma Main Business
Table 134. Hikma Latest Developments
Table 135. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Egalet Opioids Drug Product Portfolios and Specifications
Table 137. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Egalet Main Business
Table 139. Egalet Latest Developments
List of Figures
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2018-2029 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Opioids Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Global Opioids Drug Sales Market Share by Type in 2022
Figure 14. Global Opioids Drug Revenue Market Share by Type (2018-2023)
Figure 15. Opioids Drug Consumed in Pain Relief
Figure 16. Global Opioids Drug Market: Pain Relief (2018-2023) & (M Units)
Figure 17. Opioids Drug Consumed in Anesthesia
Figure 18. Global Opioids Drug Market: Anesthesia (2018-2023) & (M Units)
Figure 19. Opioids Drug Consumed in Others
Figure 20. Global Opioids Drug Market: Others (2018-2023) & (M Units)
Figure 21. Global Opioids Drug Sales Market Share by Application (2022)
Figure 22. Global Opioids Drug Revenue Market Share by Application in 2022
Figure 23. Opioids Drug Sales Market by Company in 2022 (M Units)
Figure 24. Global Opioids Drug Sales Market Share by Company in 2022
Figure 25. Opioids Drug Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Opioids Drug Revenue Market Share by Company in 2022
Figure 27. Global Opioids Drug Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Opioids Drug Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Opioids Drug Sales 2018-2023 (M Units)
Figure 30. Americas Opioids Drug Revenue 2018-2023 ($ Millions)
Figure 31. APAC Opioids Drug Sales 2018-2023 (M Units)
Figure 32. APAC Opioids Drug Revenue 2018-2023 ($ Millions)
Figure 33. Europe Opioids Drug Sales 2018-2023 (M Units)
Figure 34. Europe Opioids Drug Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Opioids Drug Sales 2018-2023 (M Units)
Figure 36. Middle East & Africa Opioids Drug Revenue 2018-2023 ($ Millions)
Figure 37. Americas Opioids Drug Sales Market Share by Country in 2022
Figure 38. Americas Opioids Drug Revenue Market Share by Country in 2022
Figure 39. Americas Opioids Drug Sales Market Share by Type (2018-2023)
Figure 40. Americas Opioids Drug Sales Market Share by Application (2018-2023)
Figure 41. United States Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Opioids Drug Sales Market Share by Region in 2022
Figure 46. APAC Opioids Drug Revenue Market Share by Regions in 2022
Figure 47. APAC Opioids Drug Sales Market Share by Type (2018-2023)
Figure 48. APAC Opioids Drug Sales Market Share by Application (2018-2023)
Figure 49. China Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Opioids Drug Sales Market Share by Country in 2022
Figure 57. Europe Opioids Drug Revenue Market Share by Country in 2022
Figure 58. Europe Opioids Drug Sales Market Share by Type (2018-2023)
Figure 59. Europe Opioids Drug Sales Market Share by Application (2018-2023)
Figure 60. Germany Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Opioids Drug Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Opioids Drug Sales Market Share by Application (2018-2023)
Figure 69. Egypt Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Opioids Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioids Drug in 2022
Figure 75. Manufacturing Process Analysis of Opioids Drug
Figure 76. Industry Chain Structure of Opioids Drug
Figure 77. Channels of Distribution
Figure 78. Global Opioids Drug Sales Market Forecast by Region (2024-2029)
Figure 79. Global Opioids Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Opioids Drug Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Opioids Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Opioids Drug Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Opioids Drug Revenue Market Share Forecast by Application (2024-2029)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs